pharmaceuticals

California Rx: State May Dive Into Generic Drug Market

The state's Legislature has overwhelmingly approved a measure that would direct the state’s top health agency to partner with one or more drug companies by January to make or distribute a broad range of generic or biosimilar drugs.

Sep 1, 2020

Image

Study Shows How Pharmaceutical Companies Maneuver To Maintain Sales, High Prices

Jan 15, 2020
Premium

Summer Setbacks: The Long Road To Lower Drug Prices Hits Some Potholes

Jul 24, 2019

Image

DAVID GOEHRING/CC BY 2.0

Oregon Settles With Pfizer -- Again

Mar 11, 2019

Image

MIKE MOZART/CREATIVE COMMONS

Trump Administration Sinks Teeth Into Paring Down Drug Prices, On 5 Key Points

Officials are working on a multi-pronged plan to promote competition, attack the drug rebate system and introduce other ways to lower prices.

Aug 10, 2018

Out-Of-Pocket Costs Often Keep Pricey New Cholesterol Drugs Out Of Reach, Study Finds

Sep 29, 2017

Sky-High Prices For Orphan Drugs Slam American Families And Insurers

Jan 18, 2017

Mylan’s Generic EpiPen — A Price Break Or Marketing Maneuver?

Sep 1, 2016

People With Obamacare Plans Filled More Prescriptions, But Had Lower Costs Ariel West Thu, 08/18/2016 - 13:00

• Read more about People With Obamacare Plans Filled More Prescriptions, But Had Lower Costs
• Log in or register to post comments

Oregon House Health Committee Grapples with Out-of-Control Drug Costs

The committee is considering three bills aimed at tackling one of the biggest cost drivers in medicine today -- outrageously priced biological wonder drugs. One bill would prevent health insurers from gouging consumers who need these medications. A second bill would require pharmaceuticals to report their profit information to the Oregon Health Authority. The third bill would free pharmacists to dispense FDA-approved biosimilars without special state barriers.

Mar 17, 2015
Premium